Abstract

Sevelamer Suspension in Children with End-Stage Renal Disease

Author(s): McElhiney Linda F

Issue: Jan/Feb 2007 - Pediatric Patients

Page(s): 20-24

Download in electronic PDF format for $75

Abstract

Control of hyperphosphatemia is a major clinical challenge in children with end-stage renal disease. The best treatment option is a calcium-based phosphate binder, but there is evidence that this treatment protocol causes long-term complications, including vascular calcifications. Sevelamer hydrochloride has been shown to be effective in reducing serum phosphorus levels and the calcium-phosphorus ion product in children on maintenance dialysis and may be key in preventing soft-tissue and vascular calcifications in such patients. Until the U.S. Food and Drug Administration approves the use of sevelamer hydrochloride in children undergoing dialysis, and a liquid dosage form becomes available, compounding pharmacists will need to prepare this unique compound for these patients.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jan/Feb 2007 Pg. 20-24	Sevelamer Suspension in Children with End-Stage Renal Disease Author(s): McElhiney Linda F
Sep/Oct 2012 Pg. 364-368	Compounded Oral Ketamine for Severe Depression, Anxiety, and Pain in a Hospice Patient with End-stage Chronic Obstructive Pulmonary Disease, Cardiopulmonary Failure, and Severe Renal Insufficiency: A Case Report Author(s): McNulty Jack P, Hahn Kristian
Jul/Aug 2003 Pg. 288-291	Basics of Compounding for Raynaud's Disease Author(s): Glasnapp Andrew
May/Jun 2003 Pg. 188-191	Treating Canine Hepatic Disease Author(s): Davidson Gigi S
Sep/Oct 2010 Pg. 382-394	Conservative Management of Chronic Kidney Disease in Cats: Recommendations for Veterinarians and Compounding Pharmacists Author(s): Meadows Richard L, Muller George
May/Jun 2016 Pg. 247-249	Extended Stability of Morphine and Sildenafil for Oral Use in Infants and Young Children Author(s): Nahata Milap C
Sep/Oct 2022 Pg. 436-439	Effects of Calcium Polystyrene Sulfonate Formulation Change from Dry Syrup to Oral Solution in Patients with Chronic Kidney Disease Author(s): Kobayashi Shunsuke, Ogawara Yuka, Imamura Yoshihiko, Kitaoka Akira, Yasu Takeo
Mar/Apr 2011 Pg. 124-128	Proton Pump Inhibitor Homogenous Suspensions: A Compounding Solution to Pediatric Gastroesophageal Reflux Disease Author(s): Corsini Lindsay, Williams LaVonn A
Jan/Feb 2012 Pg. 34-41	Compounded Pimobendan for Canine Chronic Degenerative Mitral Valve Disease and Pulmonary Hypertension Author(s): Helms Scott R, Fox Samantha, Mixon William, Vail Jane
May/Jun 2016 Pg. 257-261	Development of Extemporaneously Compounded Aripiprazole Oral Suspensions for Use in Children Author(s): Pramann Lance A, Davidow Lawrence W, van Haandel Leon, Funk Ryan S
Mar/Apr 2015 Pg. 143	Aminohippurate Sodium 200-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 293-296	Compounding for Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases Author(s): Harrington Amy, Williams LaVonn
Jan/Feb 2014 Pg. 61	Bumetanide 0.25-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2010 Pg. 108-111	Coenzyme Q10 Supplementation in the Treatment of Heart Disease Author(s): Bramwell Bethany L
Jul/Aug 1997 Pg. 242-243	Case Reports: Osteomyelitis in a Young Draft Horse; Quarter Horse Gelding with Chronic Obstructive Pulmonary Disease Author(s): Patterson Donna, Ford Peter R, Gallon Marlene D
Nov/Dec 2018 Pg. 516-526	Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4 Author(s): Polonini Hudson, da Silva Sharlene Loures, Brandão Marcos Antônio Fernandes, Bauters Tiene, De Moerloose Barbara, Ferreira Anderson de Oliveira
Jan/Feb 2019 Pg. 14-21	The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 2 Author(s): Williams LaVonn A
Sep/Oct 2006 Pg. 390	Oral Rehydration Salts (World Health Organization/United Nations Children's Fund) Author(s): Allen Loyd V Jr
Sep/Oct 2009 Pg. 367-371	Congestive Heart Failure and Other Medical Facts About Ferrets; Scout's Story: A Case Report on Treating Congestive Heart Failure in a Ferret Author(s): Williams LaVonn A, Riley Kari
Jul/Aug 2007 Pg. 338-346	Statistical Analysis of Barrier Isolator/Glovebox Glove Failure Author(s): Park Young H, Pines E, Ofouku M, Cournoyer ME